Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Multiple Myeloma × talazoparib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Breast Neoplasms 28 Triple Negative Breast Neoplasms 12 Prostatic Neoplasms 12 Ovarian Neoplasms 10 Neoplasms 10 Neoplasm Metastasis 9 Leukemia, Myeloid, Acute 5 Fallopian Tube Neoplasms 5 Small Cell Lung Carcinoma 4 Endometrial Neoplasms 4 Colorectal Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Advanced Solid Tumors 4 Pancreatic Neoplasms 3 Stomach Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Sarcoma, Ewing 2 Recurrence 2 Neuroectodermal Tumors, Primitive, Peripheral 2 Carcinoma, Renal Cell 2 Carcinoma, Ovarian Epithelial 2 mCRPC 1 Wilms Tumor 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Triple Negative Metastatic Breast Cancer 1 Thrombocythemia, Essential 1 Solid Tumor 1 Sarcoma 1 Rhabdomyosarcoma 1

Interventions

Dexamethasone 714 Bortezomib 396 Lenalidomide 383 Cyclophosphamide 305 Melphalan 233 Calcium Dobesilate 208 daratumumab 193 pomalidomide 171 carfilzomib 154 fludarabine phosphate 109 fludarabine 107 Thalidomide 106 Peripheral Blood Stem Cell Transplantation 106 Filgrastim 100 ixazomib 79 Whole-Body Irradiation 74 Mycophenolic Acid 72 Granulocyte Colony-Stimulating Factor 72 Busulfan 71 dexamethasone acetate 69 Tacrolimus 63 Prednisone 58 Cyclosporine 58 dexamethasone 21-phosphate 57 auricularum 53 isatuximab 52 elotuzumab 51 belantamab mafodotin 51 Antilymphocyte Serum 49 Etoposide 45

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02693535 2026-03-19

TAPUR

American Society of Clinical Oncology

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡